RhumbLine Advisers’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,022
Closed -$760 4391
2024
Q1
$760 Hold
4,022
﹤0.01% 4169
2023
Q4
$651 Hold
4,022
﹤0.01% 4186
2023
Q3
$1.78K Sell
4,022
-5,984
-60% -$2.73K ﹤0.01% 4121
2023
Q2
$3.69K Sell
10,006
-157,275
-94% -$134K ﹤0.01% 4133
2023
Q1
$304K Buy
167,281
+4,777
+3% +$10.4K ﹤0.01% 2612
2022
Q4
$336K Buy
162,504
+1,158
+0.7% +$3.66K ﹤0.01% 2634
2022
Q3
$486K Buy
161,346
+9,486
+6% +$33.6K ﹤0.01% 2503
2022
Q2
$486K Buy
151,860
+137,044
+925% +$742K ﹤0.01% 2516
2022
Q1
$96K Buy
14,816
+4,795
+48% +$43.4K ﹤0.01% 2895
2021
Q4
$134K Buy
+10,021
New +$110K ﹤0.01% 2905

Other funds holding HLTH

RhumbLine Advisers's HLTH Position: Q2 2024 in Review

RhumbLine Advisers sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 4,022 shares — an estimated $760 sold.

RhumbLine Advisers first reported a position in HLTH in Q4 2021 and held it in 10 quarters. The position peaked at $486K in Q3 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • RhumbLine Advisers reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 4,022 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $760.
  • RhumbLine Advisers first reported a position in Cue Health Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • RhumbLine Advisers's Cue Health Inc. Common Stock position peaked at $486K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.